TTK Healthcare Limited has announced the completion of tenure of its Independent Director Mr. N Ramesh Rajan, marking the end of his second and final term with the company. The announcement was made through a regulatory filing under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015.

Director Tenure Details

Mr. N Ramesh Rajan, holding Director Identification Number (DIN) 01628318, completed his second and final term as Independent Director on February 02, 2026. Following the completion of his tenure, he ceases to be a Director of the company and Member/Chairman of the Committees of the Board of Directors, with effect from February 03, 2026.

Regulatory Compliance

The company has confirmed that notwithstanding Mr. Rajan's retirement, the composition of the Board and its Committees continue to be in compliance with the requirements of applicable laws. This ensures that TTK Healthcare maintains its governance standards and regulatory adherence despite the directorial change.

Board Appreciation

The Board of Directors and Management of TTK Healthcare expressed deep appreciation and gratitude to Mr. N Ramesh Rajan for his extensive contribution to the company during his tenure as Independent Director. The Board extended their best wishes to him following the completion of his service.

Regulatory Filing

The disclosure was made pursuant to Regulation 30 of the Listing Regulations, read with SEBI Circular dated July 13, 2023. The company has indicated that this information is also available on its official website at www.ttkhealthcare.com . The regulatory communication was signed by Gowry A Jaishankar, DGM - Legal & Company Secretary, on February 02, 2026.

TTK Healthcare Limited has successfully completed its postal ballot process for the appointment of a new Independent Director, with shareholders demonstrating strong support for the corporate governance initiative. The company announced the voting results on January 27, 2026, following the completion of the e-voting process.

Appointment Details and Resolution Outcome

The special resolution for appointing Mr V Sundaresan (DIN: 11435475) as an Independent Director was passed with overwhelming shareholder approval. The appointment is effective from December 22, 2025, for a term of 5 years.

E-Voting Process and Timeline

The postal ballot process was conducted entirely through electronic means, in compliance with MCA circulars and SEBI regulations. The e-voting commenced on Friday, December 26, 2025, at 9.00 A.M. (IST) and concluded on Saturday, January 24, 2026, at 5.00 P.M. (IST).

Key process highlights include:

• Record Date: December 19, 2025
• Notice Dispatch: December 24, 2025 (via email to registered shareholders)
• Advertisement Publication: December 25, 2025 in Makkal Kural (Tamil) and Business Standard (English)
• Vote Unblocking: January 26, 2026, at 11.05 A.M. (IST)

Category-wise Voting Analysis

The voting participation varied significantly across different shareholder categories:

Scrutinizer Appointment and Report

The Board of Directors appointed M/s A K Jain & Associates, Practising Company Secretaries, represented by partners Mr Balu Sridhar and Mr Anil Kumar Jain, as scrutinizers for the postal ballot process. The scrutinizer submitted their report on January 27, 2026, confirming the fair and transparent conduct of the voting process.

The scrutinizer's report confirmed that no invalid votes were recorded across any shareholder category, and all procedural requirements under the Companies Act 2013 and SEBI regulations were duly complied with.

Regulatory Compliance and Documentation

TTK Healthcare ensured full compliance with regulatory requirements, including Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The voting results have been made available on the company's website and will be uploaded on CDSL's e-voting platform. The company has also filed the necessary documentation with BSE Limited and National Stock Exchange of India Limited, maintaining transparency in corporate governance practices.